Company: OSRH
Filing Date: 2025-06-23
Form Type: 424B3
Source: 0001213900-25-056351
Chunk: 4

Company: OSR Holdings, Inc.
Filing Date: 2025-06-23
Form: 424B3
Chunk 4
---
 Act. The Selling Stockholder may offer all or part
of the shares for resale from time to time through public or private transactions, at either prevailing market prices or at privately
negotiated prices. Our registration of the shares of common stock covered by this prospectus does not mean that the Selling Stockholder
will offer or sell any of the shares. With regard only to the shares the Selling Stockholder sells for its own behalf, the Selling Stockholder
may be deemed an “underwriter” within the meaning of the Securities Act. The Company has paid all of the registration expenses
incurred in connection with the registration of the shares. We will not pay any of the selling commissions, brokerage fees and related
expenses.

Our Common Stock is listed and traded on the Nasdaq
Capital Market under the symbol “OSRH.” On May 21, 2025, the last reported sale price of our common stock was $1.15
per share. We recommend that you obtain current market quotations for our Common Stock prior to making an investment decision.

We will pay the expenses incurred in registering
the shares, including legal and accounting fees. See “Plan of Distribution” beginning on page 90 of this prospectus.

Sales of our Common Stock, if any, under this
prospectus may be made by any method permitted that is deemed to be an “at the market offering” as defined in Rule 415(a)(4)
promulgated under the Securities Act. There is no arrangement for funds to be received in any escrow, trust, or similar arrangement.

We are an “emerging growth company,”
as that term is used in the Jumpstart Our Business Startups Act of 2012, and as such, have elected to comply with certain reduced public
company reporting requirements for the registration statement of which this prospectus forms a part and future filings. See “Prospectus
Summary—Implications of Being an Emerging Growth Company” and “Risk Factors—Risks Related to this Offering and
Ownership of Our Common Stock.”

Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. We urge you to read the entire prospectus, any amendments or supplements, any free writing prospectuses, and any documents incorporated by reference carefully before you